本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Chromocell Therapeutics Corp

13.50
0.0000
成交量:- -
成交额:- -
市值:8,754.76万
市盈率:-10.88
高:13.50
开:13.50
低:13.50
收:13.50
数据加载中...
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/04

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/13

SEC问询函

Form CORRESP - Correspondence
2024/02/13

SEC问询函

Form CORRESP - Correspondence
2024/02/12

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/31

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses